Gland Pharma Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 1,384 | 1,425 | 1,506 | 1,487 | 1,695 | 1,743 | 1,800 | 1,834 | |
| 58 | 44 | 58 | 84 | 63 | 111 | 61 | 69 | |
| 1,143 | 1,181 | 1,250 | 1,287 | 1,372 | 1,348 | 1,427 | 1,472 | |
| 437 | 588 | 557 | 558 | 530 | 594 | 588 | 641 | |
| 2 | 3 | 0.88 | 2 | 2 | 2 | 2 | 3 | |
| 23 | −103 | −37 | −7 | 45 | −5 | 34 | 26 | |
| 343 | 373 | 408 | 385 | 424 | 412 | 444 | 412 | |
| 23 | 7 | 12 | 8 | 4 | 10 | 4 | 7 | |
| 96 | 96 | 101 | 106 | 108 | 109 | 111 | 115 | |
| 219 | 216 | 209 | 234 | 260 | 227 | 243 | 268 | |
| 418 | 392 | 425 | 398 | 474 | 624 | 551 | 553 | |
| 322 | 296 | 324 | 292 | 366 | 516 | 439 | 438 | |
| — | — | — | — | −24 | — | — | — | |
| 299 | 288 | 313 | 284 | 362 | 506 | 435 | 431 | |
| 95 | 102 | 97 | 100 | 101 | 139 | 118 | 140 | |
| 205 | 187 | 215 | 184 | 261 | 367 | 317 | 291 | |
| Financial ratios | ||||||||
| 30.23% | 27.48% | 28.25% | 26.77% | 27.94% | 35.83% | 30.58% | 30.16% | |
| 14.79% | 13.09% | 14.31% | 12.35% | 15.42% | 21.04% | 17.61% | 15.86% | |
| 12.42 | 11.32 | 13.08 | 11.15 | 15.87 | 22.26 | 19.23 | 17.62 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.